Home › Type 2 Diabetes › NCT06296485
Safer Aging With Diabetes Monitoring
Pragmatic Clinical Trial of Continuous Glucose Monitoring-based Interventions for Safe Insulin Use in High-Risk Older Adults With Type 2 Diabetes
Who can join
Ages 75 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Age 75 years and older * Diagnosis of Type 2 Diabetes * Current treatment with insulin * Increased hypoglycemia risk (prior year hypoglycemia by self-report or utilization) * Able to communicate in English * Able to access email and the Internet Exclusion Criteria: * On renal dialysis * Dementia * Pacemaker or Automatic Implantable Cardioverter Defibrillator * Using insulin pump * Severe Mental Illness * Severe Visual Impairment * In Hospice * Current or recent CGM use
About the study
Older adults with type 2 diabetes are at higher risk for severe hypoglycemia and its related complications (including hospitalization and death) when taking insulin. This study proposes to evaluate, in a randomized clinical trial, a strategy of safe insulin prescribing based on an educational program that leverages continuous glucose monitoring to support older adults at high risk for hypoglycemia. If the aims of this project are achieved, this novel care strategy could be widely applied to reduce severe hypoglycemia episodes in older, high-risk adults with type 2 diabetes.
What is being tested
- SAGE Group Sessions (behavioral)
- Usual Care (other)
Sponsor: Kaiser Permanente · Participants: 360 · Started: May 1, 2024
Contact the study team
- Carolina Gonzalez · Phone: 866-206-2969
- Emma M Fernandez · Phone: 866-206-2969
Official record on ClinicalTrials.gov — NCT06296485
Locations in the U.S.
| California | Kaiser Permanente Sacramento, Sacramento |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.